Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg ...
Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
ScienceAlert on MSN
Caffeine in Your Blood Might Affect Body Fat And Diabetes Risk, Study Shows
The levels of caffeine in your blood could affect the amount of body fat you carry, a factor that in turn could determine ...
Breaking down the new 2025-2030 U.S. Dietary Guidelines: why the new recommendation is to "consume less alcohol for better ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Clinical research technology veteran joins to accelerate company's growth as the unified platform solution for ...
Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetesApproval based on the TN-10 phase 2 study that demonstrated a ...
MedPage Today on MSN
Sleep, Women, and Tau; Prenatal COVID and the Brain; Why FDA Rejected MS Drug
A prospective study of 39 mother-infant dyads exposed to SARS-CoV-2 during pregnancy suggested that cognitive skills in ...
In this phase 3 trial, researchers aimed to study the efficacy of tumor bed boost and moderately hypofractionated whole breast irradiation in patients with non-low-risk DCIS.
Global and genetic analyses link low physical activity to rising heart disease mortality, while higher activity levels appear ...
A new study provides novel insights into the durability of endovascular thrombectomy in patients with stroke caused by ...
Pro-Russian group NoName057(16) uses a denial-of-service tool to mobilize volunteers and disrupt sites and organization tied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results